BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
90 hedge funds and large institutions have $121M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-1
Holders Change %
-1.1%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
31
Reduced
26
Closed
18
Calls
$596K
Puts
$1.26M
Net Calls
-$666K
Net Calls Change
-$241K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$18.8M |
| 2 |
AC
Ascend Capital
Orinda,
California
|
$2.63M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
$2.3M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
$947K |
| 5 |
Millennium Management
New York
|
$1.61M |
